Quantcast

Insider Trades of HINDMAN ANDREW A. Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded ▼ Last Price Shares Held
THERAVANCE BIOPHARMA, INC. Officer 07/01/2019 Form 4 Acquisition (Non Open Market) direct 50,000 0 50,000
ACORDA THERAPEUTICS INC Officer 05/25/2018 Form 4 Sell direct 42,615 24.2639 4,503
ACORDA THERAPEUTICS INC Officer 03/08/2019 Form 4 Acquisition (Non Open Market) direct 9,045 0 15,639
ACORDA THERAPEUTICS INC Officer 02/22/2018 Form 4 Acquisition (Non Open Market) direct 5,742 0 51,048
ACORDA THERAPEUTICS INC Officer 05/13/2018 Form 4 Disposition (Non Open Market) direct 3,930 24.35 47,118
ACORDA THERAPEUTICS INC Officer 09/10/2018 Form 4 Acquisition (Non Open Market) direct 2,300 0 6,803
ACORDA THERAPEUTICS INC Officer 12/22/2018 Form 4 Acquisition (Non Open Market) direct 2,300 0 7,471
ACORDA THERAPEUTICS INC Officer 11/05/2018 Form 4 Disposition (Non Open Market) direct 879 20.28 5,924
ACORDA THERAPEUTICS INC Officer 02/21/2019 Form 4 Disposition (Non Open Market) direct 877 13.38 6,594
ACORDA THERAPEUTICS INC Officer 12/01/2017 Form 4 Automatic Sell direct 817 20.5436 45,306
ACORDA THERAPEUTICS INC Officer 12/03/2018 Form 4 Automatic Sell direct 753 20.5556 5,171







Create your free portfolio




Most Rated Stocks of Last Week

Rated stocks for NASDAQ, NYSE and AMEX

Symbol / Ratings Consensus

MSFT 83% bullish of 938 ratings Rate It

FB 76% bullish of 1583 ratings Rate It

CSCO 84% bullish of 264 ratings Rate It

BIDU 80% bullish of 100 ratings Rate It

T 73% bullish of 75 ratings Rate It

FCEL 91% bullish of 45 ratings Rate It

KMI 68% bullish of 34 ratings Rate It

AMBA 68% bullish of 22 ratings Rate It

LJPC 81% bullish of 16 ratings Rate It

CTSH 87% bullish of 15 ratings Rate It